M Takada1, T Koizumi, H Toyama, Y Suzuki, Y Kuroda. 1. First Department of Surgery, Kobe University School of Medicine, 7-5-2, Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan. moriatsu@med.kobe-u.ac.jp
Abstract
BACKGROUND/AIMS: Amphoterin is a key protein in normal neurite outgrowth and that its receptor on the cell surface, RAGE, is an important molecule for invasion. RAGE induces neurite outgrowth and regulate gene expression through NF-kappa B. Because the pancreatic cancer shows the constitutively activated NF-kappa B, the involvement of RAGE could be possible as a determinant for the metastatic ability. METHODOLOGY: To see the involvement of RAGE in pancreatic cancer, three representative human pancreatic carcinoma cells were rendered for the study which have different metastatic potential, PANC-1 and MIA PaCa-2 as the cells with high ability, BxPC-3 as those with low. The expression of RAGE (receptor for advanced glycation end-products) was examined by Western blot. RESULTS: The expression of RAGe was strong in MIA PaCa-2 and PANC-1 that have high metastatic ability. On the contrary, RAGE is expressed little in BxPC-3 whose ability is low. CONCLUSIONS: RAGE is expressed in concordant to the metastatic ability of the human pancreatic cancer cells. Control of this molecule could be a key to regulate the metastatic ability of pancreatic cancer.
BACKGROUND/AIMS: Amphoterin is a key protein in normal neurite outgrowth and that its receptor on the cell surface, RAGE, is an important molecule for invasion. RAGE induces neurite outgrowth and regulate gene expression through NF-kappa B. Because the pancreatic cancer shows the constitutively activated NF-kappa B, the involvement of RAGE could be possible as a determinant for the metastatic ability. METHODOLOGY: To see the involvement of RAGE in pancreatic cancer, three representative humanpancreatic carcinoma cells were rendered for the study which have different metastatic potential, PANC-1 and MIA PaCa-2 as the cells with high ability, BxPC-3 as those with low. The expression of RAGE (receptor for advanced glycation end-products) was examined by Western blot. RESULTS: The expression of RAGe was strong in MIA PaCa-2 and PANC-1 that have high metastatic ability. On the contrary, RAGE is expressed little in BxPC-3 whose ability is low. CONCLUSIONS:RAGE is expressed in concordant to the metastatic ability of the humanpancreatic cancer cells. Control of this molecule could be a key to regulate the metastatic ability of pancreatic cancer.
Authors: Joseph DiNorcia; Minna K Lee; Dorota N Moroziewicz; Megan Winner; Paritosh Suman; Fei Bao; Helen E Remotti; Yu Shan Zou; Shi Fang Yan; Wanglong Qiu; Gloria H Su; Ann Marie Schmidt; John D Allendorf Journal: J Gastrointest Surg Date: 2011-11-04 Impact factor: 3.452
Authors: Li Jiao; Stephanie J Weinstein; Demetrius Albanes; Philip R Taylor; Barry I Graubard; Jarmo Virtamo; Rachael Z Stolzenberg-Solomon Journal: Cancer Res Date: 2011-05-03 Impact factor: 12.701